1 Affiliations removed for initial submission as per guidelines. 6 ABSTRACT Predicting how pharmaceuticals may affect heart rhythm is a crucial step in drug-development, and requires a 7 deep understanding of a compound's action on ion channels. In vitro hERG-channel current recordings are an important step in 8 evaluating the pro-arrhythmic potential of small molecules, and are now routinely performed using automated high-throughput 9 patch clamp platforms. These machines can execute traditional voltage clamp protocols aimed at specific gating processes, 10 but the array of protocols needed to fully characterise a current is typically too long to be applied in a single cell. Shorter 
Mathematical model
We used a recently published hERG model by Beattie et al. (9) , which has a Hodgkin & Huxley-style structure. This model 87 structure has been widely used in many studies with slight modifications: the root of the model traces back to Zeng et al. (15) , 88 where the same model structure is used but with the inactivation gate modelled as an instantaneous steady-state response. Later time constant independent of the steady state. In the model that we use, the current, I Kr , is modelled with a standard Ohmic 91 expression,
where g Kr is the maximal conductance, a is a Hodgkin and Huxley (10) activation gate, and r is an inactivation gate. E K is the 93 reversal potential, also known as the Nernst potential. E K was not inferred but was calculated directly using
where R is the ideal gas constant, T is the absolute temperature, F is the Faraday constant, and z is the valency of the ions (equal to 1 for K + ). [K + ] o and [K + ] i denote the extracellular and intracellular concentrations of K + respectively, which were determined by the experimental solutions as 4 mM and 110 mM respectively. The model structure is shown in Figure 1 , where
,
Where k 1 = p 1 exp(p 2 V), k 3 = p 5 exp(p 6 V), k 2 = p 3 exp(−p 4 V), k 4 = p 7 exp(−p 8 V).
Our model consists of 9 positive parameters θ = {g Kr , p 1 , · · · , p 8 }, each of which must be inferred from the experimental data.
95
Simulations were run using Myokit (17), with tolerance settings for the CVODE solver (18) set to abs_tol = 96 10 −8 and rel_tol = 10 −10 . All codes and data are freely available at https://github.com/CardiacModelling/ 97 hERGRapidCharacterisation.
98

Statistical model and parameter inference 99
To infer model parameters from experimentally observed data under a probabilistic and Bayesian framework, we specified a 100 statistical model to relate the mathematical model and the observed experimental data:
We assumed that noise arises from a normal distribution ∼ N(0, σ 2 ). This is equivalent to writing I data Kr ∼ N(I model Kr , σ 2 ),
102
which allows us to formulate the likelihood of observing the data y given parameters φ = ln(θ) as
where t k is the time point at index k. We chose the parameter transformation φ = ln(θ) to turn our positively constrained physical model parameters to be unconstrained optimisation variables. Using Bayes' theorem, we can now write an equation for the likelihood of a parameter set given the observed data (the posterior) as p(φ, σ|y) = p(φ)p(y|φ, σ) p(y) ,
Hierarchical Bayesian model
115
We combined multiple experimental recordings using a multi-level modelling technique known as a hierarchical Bayesian 116 model. Under this framework, we assume the vector of the transformed parameters φ for a particular cell follows a multivariate 117 normal distribution which describes how these parameters are distributed between all cells, namely φ ∼ N(µ, Σ). Given our 118 choice of parameter transformation, this is equivalent to writing θ ∼ LogNormal(µ, Σ), that is the vector of parameters θ for a 119 particular cell follows a multivariate log-normal distribution. Then we used the hierarchical Bayesian model to infer the mean 120 vector µ and covariance matrix Σ across cells, and hence determined any correlation in model parameter sets between cells.
121
The parameter dependency for this hierarchical Bayesian model is shown in Figure S5 in the Supporting Material.
122
The full hierarchical Bayesian likelihood L was specified as the product of: (a) the probability of producing data y j on each cell given the parameter vector for each cell θ j and noise σ j ; (b) the probability of obtaining each individual well parameter set θ j from the 'top-level' LogNormal distribution across wells defined by the hyperparameters; and (c) the priors -the prior of the hyperparameters (also known as the 'hyper-prior') and the prior of σ j . That is,
where µ, Σ are the hyperparameters of the hierarchical model representing the mean vector and covariance matrix of the 123 individual 'low-level' parameters, and {θ j , σ j } Material Section S6, and we test the LogNormal distribution assumption in Section S8.
130
We used the inferred covariance matrix Σ to study the correlation (corr(θ)) between the model parameters, which are related
allows us to make predictions about how future experiments will behave, where (· · · ) indicates all other variables appearing in 134 Eq. 7. It can be computed using
where Θ = {µ, Σ}, a concatenation of all the individual hyperparameters within µ and Σ. The integration was approximated by 136 summing over the probability density functions which are defined by the samples of Θ.
137
Synthetic data studies
138
Before implementing experiments, we confirmed the identifiability of model parameters using our protocols and parameter
139
inference algorithms through a synthetic data study. We generated synthetic data (with added synthetic noise) with some known
140
'true' parameters θ true . First, we used the synthetic data to design and optimise our protocols and to ensure that the protocols
141
give access to sufficient information for parameter characterisation. Second, we assessed our inference methods, described in 142 the previous section, by asking how confident we are in our inferred parameters. In Supporting Material Section S6.3.1, we
143
show that our newly designed protocol, the staircase protocol (see Figure 1C ), is information-rich, in that we are able to fully 144 recover the 'true' parameter in a synthetic data study using our protocol.
145
We also tested our hierarchical Bayesian model, to ensure that it is possible to infer the underlying distribution of the 146 parameters. We generated our individual synthetic data from a predefined multivariate normal distribution, where parameters 147 are correlated. In Supporting Material Section S6.3.2, we applied our hierarchical Bayesian model analysis to the synthetic data,
148
assuming we did not know the underlying covariance between parameters, and we were able to reconstruct the correlation 149 matrix of our predefined distribution with very high accuracy. This provides us with confidence that our method is able to 150 correctly infer the underlying correlation between parameters. We describe the rationale and procedure of the synthetic data 151 study in detail in the Supporting Material Section S6.
152
Experimental methods
153
Whole-cell patch-clamp voltage clamp experiments were performed on Chinese Hamster Ovary (CHO) cells stably transfected 154 with hERG1a (Kv11.1), with temperature control set to 25 • C, using the Nanion SyncroPatch 384PE platform (Nanion
155
Technologies GmbH, Germany). The temperature of the system's 'cell hotel' was set to ∼15 • C. The machine is an automated 156 high-throughput platform, in which each run (or chip) is able to measure up to 384 wells (with one cell per well) simultaneously.
157
Single hole chips with medium resistance (Nanion order number #221102) were used. Solutions used in all measurements are 158 provided in Table S2 in the Supporting Material. are given in Section S1 in the Supporting Material. Every protocol (the entire procedure in Figure 2 ) was applied to every well.
166
Only the staircase protocol (green) was used in fitting (or calibrating) the mathematical model. We show that we can 167 fully characterise I Kr for each cell using just this one protocol, as our staircase protocol is information-rich. A comparison 168 between the staircase protocol and a previously developed protocol (9) is shown in Figure 1B and C. However, due to hardware an information-rich protocol -was adapted, and the rationale of our staircase protocol is discussed below. We designed voltage clamp protocols were used, each of them was performed 4 times: twice before E-4031 addition, and twice after, to ensure stability and reliability of the recordings. Only the staircase protocol (green, 15 seconds) was used for fitting (or calibrating) the mathematical model. All of the other 8 protocols (blue) were used for validation only. White sections indicate a non-measurement region, where cells were held at −80 mV, to allow the cells to settle to steady state between protocols (>5 s), or to allow the drug to wash in (>5 min). For details of the protocols please refer to Supporting Material (Section S1).
the staircase protocol with only voltage steps and ramps, such that it is applicable to any patch clamp machine including the 173 high-throughput automated systems.
174
A demonstration that a mathematical model is able to reproduce the experimental training data is not sufficient to conclude 
183
Protocol design
184
The underlying rationale of the staircase protocol is to force the protocol to explore the full dynamics of the system at different 
190
Two ramps are implemented before and after the main staircase. The first one is used to estimate the leak current, see the
191
next section for more details. The second one is designed to estimate experimentally the reversal potential E K by having a ramp 192 that quickly crosses the expected E K , which we expect to be in the range of −70 mV to −100 mV. However, the hERG channel large step up to 40 mV before the ramp to open the channel, so that we can record a high signal-to-noise ratio I Kr trace that goes 195 from positive to negative. An example demonstrating the use of the two ramp design is shown in Figure S2 in the Supporting
196
Material. Implementation of all of the above leads to the staircase protocol shown in Figure 2 .
197
Post-processing experimental data 198 We assumed that our observed current from hERG CHO cells under control conditions is
To ensure the currents recorded are purely I Kr , we performed the series of corrections described below. First, leak corrections
200
were applied to all measurements to eliminate I leak . Second, E-4031 subtraction was applied to remove I endogenous (the sum of 201 any native voltage-dependent ion currents that were present in CHO cells besides the overexpressed hERG). We also describe 202 our partially automated quality control criteria to select and ensure high quality I Kr recordings. 
As shown in Figure 2 , a period of ∼5 min was allowed for the E-4031 block to reach equilibrium. All currents shown or used in 209 this study are the leak corrected currents measured in control conditions minus the leak corrected currents that remained after 210 E-4031 addition, which we assume yields uncontaminated I Kr .
211
Leak correction
212
A leak step was implemented to infer the leak current, where we assumed
Here, g leak is the leak current conductance and E leak is the leak current reversal potential. Since this model is linear we can 214 estimate its parameters g leak , E leak in two ways; either by using two points, or better by using a linear ramp. 
where I est. 1 leak , I est. 2 leak are leak currents estimated using Eq. 12. After the experiments, we applied a strict set of criteria as an automated selection process for quality control of our experimental 237 data. The details of our criteria are summarised in Table 1 . We applied a strict cut-off for seal resistance (R seal ), cell capacitance 238 (C m ), and series resistance (R series ) through the whole set of measurements, set by our first quality control criterion (QC1 183 out of 384 wells and for the full dataset is 124 out of 384 wells, which can be performed within one hour.
261
RESULTS
262
High-throughput experimental recordings 263 Figure 3 shows the voltage clamp recordings measured with the 9 different protocols, and the corresponding voltage protocols.
264
All results shown are the first of the two repeats of our recordings. Our analysis was repeated for the second of the two repeats
265
to ensure the reproducibility of our results in the same cells: the intrinsic (within-cell) variability is sufficiently small to be 266 negligible, see Figure S12 in the Supporting Material.
267 Figure 3A shows the staircase protocol (black) and the corresponding experimental recordings (blue). The middle panel shown as red lines, is fitted only to the data recorded under the staircase protocol that is shown in Figure 4A . The result of 283 the fitting for a single cell is shown in the middle panel of Figure 4A , demonstrating an excellent fit between experimental 284 measurement and simulated current. The inferred parameters are shown and studied in detail in the next three sections.
285
In Figure 4B -I, we show the results of the validation predictions under 8 other protocols. We validated our trained model by 286 testing its ability to predict independent experimental outcomes under different protocols, which were measured in the same 287 cell. All validation predictions were performed by using the inferred parameters in the fit to the staircase protocol ( Figure 4A 
Using this RRMSE quantification, the difference in the absolute size of the current across cells due to varying conductance is small discrepancies in the predictions, for example in Figure 6B in the 90th percentile predictions. But overall these results
307
demonstrate that all our 124 models make very good predictions for the recorded current kinetics.
308
Next, we first qualitatively inspect the variability in the hERG kinetics measurements. Since we measured the I Kr using 309 exactly the same experimental set-up for each cell, we can clearly see the variability between measurements in all of the 310 recordings, as illustrated in Figure 5 . Different protocols demonstrate different levels of variation. It is clear that, amongst the 6 311 protocols, the staircase protocol and the two I-V protocols show the strongest variation between measurements.
312
To investigate this further, we have used our mathematical model to study the variability in the parameter values that 313 could drive the observed variability in the outputs. Figure 7 shows the inferred parameter values which are used in the model 314 predictions in Figure 5 . Since we assume all cells share the same mechanistic model underlying the hERG currents our inferred 315 cell-specific model parameters capture the cell-to-cell variability, or rather experiment-to-experiment variability. In Figure 7 , 
318
This agreement gives us further confidence that our high-throughput method is reproducible and biophysically meaningful. We
319
can also see that there is more variability in some parameters than others, also seen in the previous study (9).
320
A hierarchical Bayesian modelling approach to characterise well-to-well variability 321 We applied the hierarchical Bayesian model to analyse the variability within the experimental recordings and correlations 322 between inferred well-to-well parameter sets. The result of applying our hierarchical model is shown in Figure 8 The staircase protocol which is used as the calibration protocol, the activation current-voltage (I-V) protocol, the steady-state inactivation I-V protocol, the hERG screening protocol, the DAD-like protocol, the EAD-like protocol, and the cardiac action potential-like protocol at 0.5 Hz, 1 Hz and 2 Hz, respectively. All the model calibration results and validation predictions are shown in the top panels (red), and are compared against the experimental recordings shown in the bottom panels (blue). Magnifications of the green shaded regions are shown underneath each panel to reveal the details of the spikes, in which our models show extraordinarily good predictions to the details. The normalised current for all protocols are shown except for the activation I-V protocol and the steady-state inactivation I-V protocol where the summary statistic I-V relationships are shown. 
Right y-axis:
The marginal posterior predictive distributions p(θ | · · · ), which are assumed to follow a multivariate log-normal distribution for each parameter, are shown as red curves. They are the inferred underlying distribution between cells for each of the parameters. First, it is much easier to obtain a stable measurement, and one can worry less about current "rundown" during the protocol as 359 compared to traditional I-V and τ-V protocols. Second, given its short duration, it is easy to repeat the measurement, to examine 360 within-cell reproducibility/variability. Third, our staircase protocol can be used to rapidly create cell-specific models of kinetics
361
(which is much harder to do using the more time-consuming traditional I-V and τ-V protocols).
362
We have shown that our 15 second staircase protocol can be performed in an automated high-throughput system. We have
363
found that each of the resulting 124 models is consistent with previous manual patch clamp results (limited to 9 cells) (9),
364
implying that these methods are reproducible. We can now easily produce large data sets for further analysis, which is usually 365 difficult, if not impossible, to achieve with manual patch clamp. The predictions of the cell-specific models are not perfect, as we 366 examined in Figure 6 , and there may be room for improvement in terms of the model structure and further optimisation of the 367 calibration protocol. But we are able to calibrate our model to the extent that it can replicate both experimental training data and 368 predict validation data very well (Figure 4 ). Our models can predict the current response to the physiologically-relevant action 369 potential protocols, demonstrating that our I Kr models could be useful in predicting cardiac electrical activity in both healthy 370 and arrhythmic situations (9). This provides assurance that our cell-specific models, which are constructed in a high-throughput 371 manner, have great potential for future uses.
372
For example, our method can potentially be adapted and used to investigate not only how much the hERG channel is blocked 373 by a drug, but also how that drug influences channel kinetics. This might be useful for the CiPA initiative, as both automated 374 high-throughput systems and in silico modelling constitute the core of the initiative (24, 25). Our approach may give us a 375 better understanding of the pharmacological properties of drugs in the screening process and hence a better pharmaceutical 376 safety assessment. We can also incorporate the cell-to-cell or experiment-to-experiment variability in the in silico modelling 377 as part of the uncertainty quantification for safety-critical predictions (14). Furthermore, such rapid characterisation using 378 high-throughput systems can benefit precision and personalised medicine. For example, when using human induced pluripotent 379 stem cell-derived cardiomyocytes (hiPSC-CMs) in personalised medicine, as described in (26), characterisation of ion current 380 kinetics may need to be taken into account, in order to tailor accurate cell line-specific models.
381
With our 124 cell-specific hERG models, we are able to study experiment-to-experiment variability in the hERG channel.
382
Such experiment-to-experiment variability is captured using our hierarchical Bayesian model, where the posterior predictive 383 distribution is constructed and describes the underlying variability of the parameters (Figure 8) . Instead of using a series of The source of variability 389 We have successfully quantified the variability between wells via our inferred model parameters. However, the underlying cause presence of subunits, phosphorylation states, or suchlike. The other possibility is that ion channel kinetics are precisely identical parameters from each well. Below we discuss hints in our results as to which of these extremes is the leading cause of variability.
395
As mentioned in the rationale of the staircase protocol, the 100 ms ramp at 14.41 s was introduced to estimate experimentally 396 the hERG reversal potential E j K in each of the j wells, for details see Figure S2 . Figure 10 shows an example of our E extra-and intra-cellular solutions and were recorded at (almost) the same temperature. We would therefore expect the real 401 variability in reversal potential to be much smaller than this observed variability.
402
A hypothesis then, is that reversal potential E K really occurs at the Nernst calculated value, and observed deviations from 
411
This is strong circumstantial evidence -a smoking gun -suggesting that the majority of the observed variability in 412 parameters may be due to well-well variability in patch-clamp artefacts rather than cell-cell variability in ion channel kinetics.
413
Building a more complete mathematical model of such patch clamp artefacts is part of our future plans. We should also note 414 that despite patch clamp artefacts being an apparent cause of parameter variability, they are not necessarily larger artefacts in 415 this automated system than might be expected in manual patch clamp.
416
Finally, if we were to believe that the observed variability here arises from experimental artefacts, then only the uncertainty 
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SUPPORTING MATERIAL
513
An online supplement to this article can be found at URL. All codes and data are freely available at https://github.com/
